Novamed's Medley acquisition review in Brazil gets new round of queries
The Brazilian competition authority has opened a new round of market testing in its review of Novamed’s proposed acquisition of Medley Farmacêutica from Sanofi, asking competitors about six pharmaceutical categories where...To view the full article, register now.
Already a subscriber? Click here to view full article